Product Images Spironolactone

This is a bottle of Spironolactone, a medication used for treating high blood pressure, edema, and heart failure. This bottle contains 30 tablets, each of 25 mg strength. The medication is packaged by acompany named RemedyRepack Inc. in Indiana, Pennsylvania. The manufacturing company is Amneal Pharma, based in Ahmedabad, India. The expiration date andlot number are not provided. The directions for use should be referred to the package insert. The medication should be stored at a temperature of 20-25°C and kept away from children.*

Spironolactone is a tablet medication with a strength of 25mg. Each pack contains 100 tablets and is meant for prescription use only. The product is manufactured by Amneal Pharma, based in Ahmedabad, India, with the source NDC number being 53746-0511-01. The lot number and expiration date are not available, and the product is repackaged by RemedyRepack Inc, located in Indiana, PA. The medication should be stored within the temperature range of 20-25°C (58-77°F), and excursions are allowed to 15-30°C (59-86°F). Directions for use should be followed as indicated on the package insert to achieve the desired results.*

Spironolactone is a medication that comes in tablet form, with each tablet containing 25 mg of the active ingredient. Each pack has 30 tablets and is packaged by Orepack. The medication is only available with a prescription and has an NDC number of 70518-0455-02. The lot number and expiration date are not available. The medication is manufactured by Amneal Pharma in Ahmedabad, India. It is important to keep this medication out of the reach of children and to follow the directions for use found in the package insert. It should be stored at a temperature between 20-25°C (58-77°F) but can be subjected to excursions between 15-30°C (59-86°F) as permitted by USP. The medication is repackaged by RemedyRepack Inc. in Indiana, PA.*

This text appears to be a set of statistical information for two different groups - one treated with Spironolactone and the other with Piaceto. The sample sizes for each group are indicated, and a log-rank p-value is reported as being less than a certain threshold (<0.001). However, without additional context, the meaning of this statistical significance cannot be determined.*

This appears to be a table with various columns containing study variables such as age, sex, race, LVEF, diabetes, creatinine, potassium, and medication use (digoxin, ACEI, Bet Blocker, spironolactone, and placebo). There also seems to be some statistical analysis comparing spironolactone and placebo in terms of their effectiveness. However, the table contains some unclear and unidentifiable characters, making it difficult to determine the full context of the data presented.*